A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation. Issue 3 (11th February 2016)

• Record Type: Journal Article
• Authors: Wang, Fang; Yang, Siqian; Hua, Dawei; Yuan, Jian; Huang, Chaobo; Gao, Qinwei
• Is Part Of: Journal of biomaterials science. Volume 27:Issue 3(2016)
• Page Start: 276
• Page End: 289
• Publication Date: 2016-02-11
• Subjects: Paclitaxel -- chitosan -- folic acid -- microparticle -- tumor targeting; Polymers -- Biocompatibility -- Periodicals; Biomedical materials -- Periodicals; 572.33
• DOI: 10.1080/09205063.2015.1121366
• Languages: English
• ISSNs: 0920-5063

Abstract

Abstract: A new chitosan microparticles loading paclitaxel (PTX) for application as an oral delivery system were developed using a novel double emulsion crosslinking method. To improve the targeted effect, folic acid (FA) was introduced onto the surface of microparticles using chemical method. The method was based on Schiff reaction between amino group of chitosan and carboxyl group of FA, and folate-chitosan (FA-CS) conjugate was characterized using infrared spectrum analysis (FT-IR), and the microparticles were named as FA-CS-PTX/MPs. FA-CS-PTX/MPs had larger size of average diameter 223.6 nm, while PTX-loaded chitosan microparticles (CS-PTX/MPs) had 179.1 nm average diameter. The zeta potential of CS-PTX/MPs and FA-CS-PTX/MPs was 22.3 and 33.1 mV, respectively. SEM and TEM showed both the two microparticles had well-defined spherical structure. The in vitro drug release was studied under different pH conditions, and a two-phase kinetics model was found to be the most adequate kinetic model. Furthermore, the cytotoxicity activities of drug-carriers against L929 cells and the cellular uptake of PTX-loaded microparticles against HepG2 cells were investigated. Results demonstrated that FA-CS-PTX/MPs might be a promising drug carrier for promoting PTX cellular uptake and could be used as a potential tumor-targeted drug vector.